We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Rush Enterprises Class A
RUSHA
$6.23B
| $3.62M | 0.01% |
175,142
-61
| -0% | -$1.19K |
|
|
RYZ
952
Ryerson Holding Corp
RYZ
$1.45B
| $3.59M | 0.01% |
303,401
+293,001
| +2,817% | +$2.89M |
|
953
Core Laboratories
CLB
$561M
| $3.58M | 0.01% |
+95,123
| New | +$4.27M |
|
954
Federal Agricultural Mortgage
AGM
$2.54B
| $3.58M | 0.01% |
42,845
-4,229
| -9% | -$352K |
|
955
Liberty Global Class A
LBTYA
$3.46B
| $3.57M | 0.01% |
156,967
+69,667
| +80% | +$1.64M |
|
956
Team
TISI
$75.7M
| $3.55M | 0.01% |
22,236
+14,026
| +171% | +$2.38M |
|
957
Graco
GGG
$13.5B
| $3.54M | 0.01% |
68,117
+37,494
| +122% | +$1.79M |
|
958
Duluth Holdings
DLTH
$151M
| $3.54M | 0.01% |
+336,060
| New | +$3.13M |
|
|
DHC
959
Diversified Healthcare Trust
DHC
$2.04B
| $3.54M | 0.01% |
418,994
+183,094
| +78% | +$1.54M |
|
960
Winmark
WINA
$1.36B
| $3.52M | 0.01% |
17,765
+15,766
| +789% | +$2.84M |
|
961
Sportsman's Warehouse
SPWH
$46.4M
| $3.52M | 0.01% |
438,151
+206,925
| +89% | +$1.46M |
|
962
Worthington Enterprises
WOR
$2.79B
| $3.49M | 0.01% |
134,099
-45,915
| -26% | -$1.08M |
|
|
CEQP
963
DELISTED
Crestwood Equity Partners LP
CEQP
| $3.48M | 0.01% |
+113,041
| New | +$3.72M |
|
964
ArcBest
ARCB
$3.07B
| $3.48M | 0.01% |
126,212
+73,612
| +140% | +$2.13M |
|
965
First Financial Corp
THFF
$962M
| $3.46M | 0.01% |
75,584
+3,705
| +5% | +$163K |
|
966
National Grid
NGG
$79.9B
| $3.43M | 0.01% |
61,966
-3,156,316
| -98% | -$162M |
|
967
Woori Financial
WF
$17B
| $3.42M | 0.01% |
113,184
+38,100
| +51% | +$1.17M |
|
968
Great Southern Bancorp
GSBC
$873M
| $3.38M | 0.01% |
53,360
+28,099
| +111% | +$1.7M |
|
969
Analog Devices
ADI
$187B
| $3.33M | 0.01% |
27,999
+5,330
| +24% | +$601K |
|
970
Bausch Health
BHC
$2.37B
| $3.31M | 0.01% |
110,400
-177,900
| -62% | -$4.62M |
|
971
Century Communities
CCS
$1.96B
| $3.3M | 0.01% |
+120,660
| New | +$3.53M |
|
972
Ituran Location and Control
ITRN
$1.02B
| $3.3M | 0.01% |
131,330
+8,116
| +7% | +$199K |
|
973
Ultrapar
UGP
$6.42B
| $3.3M | 0.01% |
+527,009
| New | +$2.68M |
|
974
Delek Logistics
DKL
$3.15B
| $3.3M | 0.01% |
103,167
+10,004
| +11% | +$318K |
|
975
1st Source
SRCE
$2.1B
| $3.28M | 0.01% |
63,209
+28,267
| +81% | +$1.42M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.